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The pharyngeal glands of Caenorhabditis elegans are one of five cell types in the pharynx. The transcription factor HLH-6 is required for
gland development and function, and is specifically expressed in pharyngeal glands. As a first step to understanding specification of pharyngeal
glands, we analyzed the promoter of hlh-6 to identify the elements required for gland-specific expression. Our experiments identified three distinct
regulatory elements required for hlh-6 expression: a PHA-4-binding site and two new elements, HRL1 and HRL2 (for hlh-6 regulatory elements 1
and 2). The three elements employ a simple logic for producing cell-type-specific expression: the PHA-4 site restricts expression to the pharynx,
HRL2 restricts expression in both a position and lineage-dependent manner, and HRL1 restricts expression to a subset of cell types. In isolation,
these three elements have little or no enhancer activity but in combination they produce robust, gland-specific expression. These findings describe
a combinatorial code for gland-specific expression and suggest that similar codes may be employed for specification of other pharyngeal
cell types.
© 2006 Elsevier Inc. All rights reserved.Keywords: Gland; hlh-6; Digestive tract; Gene regulation; Combinatorial code; Pharynx; C. elegansIntroduction
A central question in development is how distinct cell fates
are specified within the context of a developing organ. In
particular, cells must be instructed to have “organ identity” to
ensure participation in organ development and function, but
must also be given a cell-type-specific identity. Although
examples of organ identity genes are known, how their activity
is integrated with cell-type-specific information remains largely
unclear (Bergstrom et al., 2002; Gaudet and Mango, 2002;
Weatherbee et al., 1998). A simple model is that cell fates within
an organ are specified by the successive restriction of their
developmental potential. In such a model, an organ identity
gene restricts cellular potential to organ-specific fates, while
other factors further restrict identity to a single cell type. These
other factors could correspond to lineage information, posi-
tional information (either along an axis or in relation to⁎ Corresponding author. Fax: +1 403 270 0737.
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doi:10.1016/j.ydbio.2006.09.036neighboring cells), or even the time at which a cell is born
(Campbell, 2005).
The pharynx of Caenorhabditis elegans is an excellent
system in which to study cell fate specification in an organ. The
pharynx (or foregut) is a neuromuscular organ that draws in food
from the environment and initiates digestion. The pharynx is
composed of 80 cells, representing five distinct cell types: mus-
cles, marginal cells, neurons, epithelia and glands (Albertson
and Thomson, 1976). Previous work demonstrated that
specification of pharyngeal cells is dependent on the FoxA
transcription factor PHA-4 (Horner et al., 1998; Kalb et al.,
1998). However, how distinct cell fates within the pharynx are
specified is largely unknown. To address this question, we are
focusing on the pharyngeal glands. The glands are five cells
that are located in the posterior bulb of the pharynx and have a
distinct morphology, including cytoplasmic projections that
extend anteriorly and open into the pharyngeal lumen
(Albertson and Thomson, 1976). All five gland cells are
descendents of the MS blastomere, one of two blastomeres
(ABa and MS) that give rise to pharyngeal cells (Sulston et al.,
1983).
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analyses to identify a pharyngeal gland-specific gene, hlh-6,
that is required for expression of several gland-specific markers
(Smit and Gaudet, in preparation). The hlh-6 gene encodes a
bHLH transcription factor that is expressed in all five
pharyngeal glands (McKay et al., 2003; Smit and Gaudet, in
preparation). HLH-6 appears to directly regulate a battery of
gland-specific genes and hlh-6 is required for normal gland cell
development and function. However, gland cells are still present
in hlh-6 mutants, suggesting that specification of pharyngeal
glands is controlled by factors acting upstream of hlh-6. Thus,
by identifying factors that regulate hlh-6, we should be able to
identify factors involved in gland cell specification. Character-
ization of the cis-acting elements provides tools for the
identification of the trans-acting factors, as well as revealing
the logic of how the elements function together to generate a
cell-type-specific expression pattern.
In the present paper, we describe our analysis of the hlh-6
promoter and demonstrate that three distinct cis-elements
function together to generate pharyngeal gland-specific expres-
sion. The regulatory logic is consistent with a model of com-
binatorial restriction of developmental potential. As expected,
we find that hlh-6 is a direct target of PHA-4, which restricts
hlh-6 expression to the pharynx. hlh-6 expression is further
restricted by two additional promoter elements: HRL1, which
restricts expression to neurosecretory cells (glands and
neurons), and HRL2, which imparts both positional (posterior)
and lineage (MS-derived cells) restrictions. Importantly, the
three elements generate a gland-specific expression pattern but
do not themselves have gland-specific activity. Thus, hlh-6
appears to be a point of integration for multiple inputs that
together may define pharyngeal gland identity.
Materials and methods
Worm strains
Standard nematode handling conditions were used (Brenner, 1974). Strains
used were N2 and GD72 hlh-6(tm299)/dpy-10(e128) unc-4(e120).
Computational searches for probable HLH-6 site
Pharyngeal glandmotif 1 (PGM1) was identified computationally and shown
to be a probable HLH-6 response element (Smit and Gaudet, in preparation). We
used MotifMatcher (http://www.cse.ucsc.edu/~kent/improbizer/motifMatcher.
html) to search the hlh-6 promoter for the best match to the PGM1 position
weight matrix.
Comparison of C. elegans and C. briggsae sequence
Caenorhabditis briggsae promoter sequence was extracted using the Batch
Sequence function of WormBase (WS140; Chen et al., 2005; WormBase, 2005).
The Ce-hlh-6 and Cb-hlh-6 promoter sequences were aligned using DotLet,
with a 60–65% threshold over 21-nt windows (Junier and Pagni, 2000).
Construction of plasmids
Deletions and mutations of sequence in the hlh-6 promoter were cloned
using standard procedures. The original hlh-6∷YFP reporter (pGD62) is
described elsewhere (Smit and Gaudet, in preparation). Enhancer constructswere built using synthetic oligonucleotides that were cloned into the
promoterless GFP vector pPD95.77, kindly provided by Andrew Fire. Clones
were verified by restriction digests and sequencing. For the enhancer sequences,
we used the following insert sequences (sequences of the individual motifs are
capitalized):
3xHRL1b: cacGTCGGAAGcctcGTCGGAAGtcatGTCGGAAG
3xHRL1b-mut: cacGTCTAGAGcctcGTCTAGAGtcatGTCTAGAG
3xHRL1c: tcgGTGGCTAAcacgGTGGCTAAcacgGTGGCTAA
3xHRL2a: tcgacTCAATAAATAATgtTCAATAAATAATctTCAATAAATAAT
3xHRL2c: tcgaCAAATAAATATCatCAAATAAATATCgtCAAATAAATAT
1xPHA-4: agcttccgatTGTTTGCacagcatg
3xPHA-4: agcttccgatTGTTTGCacagccgatTGTTTGCacagccgatTGTTTG-
Cacagcatg
Details of plasmids and cloning strategies are available upon request.
Construction of transgenic lines
hlh-6 reporter constructs were injected at 20 ng/μl together with two
transformation markers: 50 ng/μl pRF4[rol-6(su1006)], which confers a
dominant Roller phenotype, and 30 ng/μl pJM67 (elt-2∷GFP∷LacZ) (Mello
et al., 1991). The intestine-specific elt-2 reporter served as an independent
marker for transgenic arrays when scoring expression (Fukushige et al., 1998).
In some cases, we injected reporters at a higher concentration (70 ng/μl
reporter, 40 ng/μl pRF4 and 30 ng/μl elt-2∷GFP-LacZ) to detect weaker
expression. We also tested inactive constructs (Δ140, ΔPHA and Δ213Δ2c)
at this higher concentration to verify their lack of expression. Enhancer
constructs were injected at 50 ng/μl with 40 ng/μl pRF4 and 10 ng/μl
ges-1∷mRFP∷HIS2B. This intestine-specific ges-1 reporter served as an
independent marker for transgenic arrays when scoring expression (Aamodt et
al., 1991). Exceptions to these injection conditions were constructs containing
the 3xPHA-4 insert, which appeared to be toxic at 50 ng/μl, and thus were
injected at 20 ng/μl together with 50 ng/μl pRF4 and 30 ng/μl elt-2∷GFP-LacZ
or ges-1∷mRFP∷HIS2B. For all constructs, a minimum of two independent
transgenic lines was analyzed. Data were collected from mid-stage (L2–L4)
larvae; there was no evidence of differences in expression in the different larval
stages.
Results
Identification of a minimal hlh-6 promoter
Previous experiments demonstrated that an hlh-6 reporter
is expressed exclusively in pharyngeal gland cells and that
this expression likely reflected the endogenous expression
pattern of hlh-6 (Smit and Gaudet, in preparation). The hlh-6
reporter contained 1175 bp of sequence upstream of the
predicted ATG of the hlh-6 coding region (pGD62; Fig. 1).
This fragment included nearly all intergenic sequence (1175
of 1190 bp) between hlh-6 and its closest upstream neighbor,
T15H9.2.
We generated a series of deletions from the 5′ end of the hlh-6
promoter and found that 241 bp of upstream sequence was
sufficient to direct pharyngeal gland-specific expression.
Reporters with 5′ deletions up to −747 bp (Δ747; positions
relative to the ATG) or −568 bp (Δ568) behaved identically to
the full-length reporter, while deletion to −241 bp (Δ241)
showed a modest decrease in expression (Fig. 1). Further
deletion from −241 to −140 (Δ140) completely abolished
reporter expression, indicating the presence of necessary
promoter elements in this region. To verify that Δ140 was
inactive, rather than weakly active, we re-injected the construct
Fig. 1. (A) Schematic of the full-length hlh-6∷YFP reporter, containing all 1175 bp of intergenic sequence from the ATG of hlh-6 to just downstream of the stop codon
of the next upstream gene, T15H9.2. (B) Diagram of the pharynx showing the gland cell bodies: light grey cells are g1 glands, dark grey are g2 glands (modified from
Albertson and Thomson, 1976). (B–F) Progressive deletions from the 5′ end of the hlh-6 promoter identified a minimal 241 bp fragment sufficient for gland-specific
expression. Fluorescence images of representative animals carrying hlh-6∷YFP transgenes show pharyngeal gland-specific expression. Dashed lines indicate the
boundaries of the pharynx. Anterior is to the left. Bar graphs represent the percentage of transgenic animals (as assessed by intestine-specific elt-2∷GFP∷LacZ
expression) with gland-expressed YFP. Black bars represent strong expression, grey bars represent weak expression, and white represents no observable expression
(after Johnson et al., 2001). Deletion of sequence to −747 (C) or −568 (D) had no observable effect on gland-specific YFP expression. (E) The minimal 241 bp
promoter (Δ241) activated slightly weaker gland-specific expression. (F) Further deletion to −140 bp (Δ140) eliminated expression.
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(data not shown). We therefore refer to the Δ241 promoter
fragment as the “minimal hlh-6 promoter” (min-hlh-6), as this
sequence was capable of activating strong, gland-specific
expression.
Autoregulation of hlh-6
Two lines of evidence indicate that sequences upstream of
the 241 bp minimal promoter (min-hlh-6) contribute to hlh-6
expression but are not required for generating gland-specific
expression. First, expression of min-hlh-6 was slightly but
consistently weaker than expression from Δ568,Δ747 and full-
length reporters (Fig. 1). Second, while deletion from −241 to
−140 eliminated min-hlh-6 activity (Δ140), the same deletion
did not completely eliminate activity in the context of a larger
promoter fragment (Δ747Δmin; Fig. 2A). Although greatlyreduced, expression of Δ747Δmin was still gland-specific,
suggesting the presence of one or more enhancers in the −747 to
−241 region that act redundantly with sequences contained
within min-hlh-6. HLH-6 acts through PGM1 sites (pharyngeal
gland motif 1; Smit and Gaudet, in preparation), which contain
E-boxes (CAnnTG, the binding sites for bHLH proteins;
Ephrussi et al., 1985). The hlh-6 promoter contains possible
occurrences of PGM1 at −427 and −349 (Fig. 2A), within the
−747 to −241 region, and these autoregulatory sites could
account for the weak activity of the Δ747Δmin promoter
fragment.
To test the possibility that hlh-6 regulates its own expression
through either or both of the sites at −427 and −349, we
mutated the E-box sequences (from CAGGTG to aAGcTt and
CAGATG to tctAga, respectively) in the context ofΔ747Δmin.
Because Δ747Δmin initially showed only weak expression in
10% of transgenic hatchlings, we re-injected this construct and
Fig. 2. The hlh-6 promoter contains two possible HLH-6-binding sites. (A) A region containing candidate HLH-6 sites made a small contribution to hlh-6 expression.
Bar graphs are as in Fig. 1. The region containing probable HLH-6 sites activated weak gland-specific expression in the absence of the critical −241 to −140 sequence
(Δ747Δmin). This weak expression was dependent on a pair of probable HLH-6-binding sites, indicated by black rectangles. “(high)” indicates that reporters were
tested at a relatively high concentration (see Materials and methods). (B) The position weight matrix for PGM1, the probable HLH-6 response element, was defined
computationally (Smit and Gaudet, in preparation). The consensus is shown below the matrix, with the E-box underlined. The best matches to PGM1 were found at
−427 and −349; the E-boxes are underlined.
298 I. Raharjo, J. Gaudet / Developmental Biology 302 (2007) 295–308its derivatives at a 3.5-fold higher concentration to obtain more
consistent expression (e.g., Δ747Δmin(high)). In wild-type
animals, the higher concentration of Δ747Δmin resulted in
weak gland expression in 91% of transgenic animals (Fig. 2A,
Table 1). Mutation of either of the two E-boxes (ΔE1 and ΔE2)
reduced expression, while simultaneous mutation of both sites
(ΔE1E2) abolished expression (Fig. 2A). This result indicated
that both E-box sequences contributed to the activity of
Δ747Δmin.
To test the possibility that these sites responded to HLH-6, we
tested the activity ofΔ747Δmin in hlh-6mutants (Table 1), again
using a relatively high concentration of reporter, which gives
consistent expression in wild-type transgenics. We next injected
Δ747Δmin into an hlh-6/dpy-10 unc-4 strain and examined
expression in transgenic progeny. hlh-6 homozygotes die as L1
larvae and thus we scored expression in newly hatched animals.
Only 73% of transgenic hatchlings expressed YFP in their glandsTable 1
Expression from the distal region of the hlh-6 promoter is hlh-6-dependent
hlh-6 reporter Parental genotype % Gland expression
hlh-6 min (−241 bp) +/+ 97 (n=175)
hlh-6 min (−241 bp) hlh-6/dpy-10 unc-4 100 (n=62)
Δ747Δmin a +/+ hatchlings 91 (n=44)
Δ747Δmina hlh-6/dpy-10 unc-4 hatchlings 73 (n=45)
Δ747Δmina hlh-6/dpy-10 unc-4 survivors 95 (n=50)
a For these experiments, the reporter concentration was increased to give
stronger expression than that shown in Fig. 2B.(Table 1), suggesting that the expected¼ hlh-6 segregants did not
express Δ747Δmin. Consistent with this hypothesis, when we
scored surviving progeny (>L2, the hlh-6(+) progeny) we found
that 95% of these animals expressed YFP in their glands (the
5% negative animals likely represent mosaic loss of the
transgene). In contrast, min-hlh-6 was expressed in 100% of
transgenic hatchlings from hlh-6/dpy-10 unc-4 parents. Thus,
the promoter region from −747 to −241 required HLH-6 for
its activity, while the region from −241 to −1 was HLH-6-
independent. The simplest explanation is that hlh-6 is itself a
target of HLH-6; such autoregulation is a common feature
among transcription factors (Edlund and Jessell, 1999). For
purposes of dissecting the hlh-6 promoter, subsequent
analyses were performed using min-hlh-6 to eliminate auto-
activation.
hlh-6 is a probable direct target of PHA-4
The most obvious candidate regulator of hlh-6 expression is
PHA-4, as PHA-4 is thought to directly regulate most or all
genes that are expressed in the pharynx (Gaudet and Mango,
2002). We therefore searched the minimal hlh-6 promoter for
the PHA-4 consensus sequence (TRTTKRY, except TATTTAT;
where R=A or G, K=G or T, and Y=C or T; Gaudet and
Mango, 2002; Overdier et al., 1994) and found three such
sequences. Deletion analysis indicated that a region from −92 to
−113, which contained a single predicted PHA-4-binding site at
−105, was required for reporter expression (Fig. 3A; Δ56–136
Fig. 3. A probable PHA-4-binding site is required for hlh-6 reporter expression. (A) Deletion analysis revealed that a region from −113 to −91 (compareΔ56–136 to
ΔPHAflank) was required for hlh-6 expression. Bars graphs are as in Fig. 1. Possible PHA-4 sites are indicated by arrowheads (down arrowhead indicates a site on the
top strand, up arrowhead indicates a site on the bottom strand). Mutation of the consensus PHA-4-binding sequence in this region (from TGTTTGC to TaTcTGC)
eliminated reporter expression (ΔPHA). (B) Three copies of the probable PHA-4 site from the minimal hlh-6 promoter activated pharyngeal expression of an
otherwise inactive promoterless GFP reporter (pPD95.77; C). In both images, arrowheads indicate expression of the transgenic marker elt-2∷GFP∷LacZ in gut nuclei.
299I. Raharjo, J. Gaudet / Developmental Biology 302 (2007) 295–308andΔPHAflank). To test the requirement for this predicted PHA-
4 site, we generated a site-specific mutation (from TGTTTGC to
TaTcTGC) that abolished the PHA-4-binding site (ΔPHA). This
mutation eliminated the activity of the hlh-6 minimal promoter
even when the construct was injected at higher concentrations
(data not shown), demonstrating that this site was required for
expression and suggesting that hlh-6 is a direct target of PHA-4.
This result was consistent with the behavior of other PHA-4
targets, in which mutation of a single PHA-4-binding site
abolished promoter activity (Gaudet and Mango, 2002). This
result also indicated that the candidate PHA-4 sites at −90 and
−150 were not sufficient for expression and may not be
functionally relevant. Similarly, deletions that removed the
predicted PHA-4 sites at −90 (Fig. 3A) or −150 (Fig. 4) did not
abolish activity.
A second piece of evidence that the TGTTTGC sequence
was a PHA-4-binding site came from in vivo enhancer assays.
Previous analysis showed that three copies of a PHA-4
consensus sequence upstream of a basal promoter (Δpes-10)
activated expression in pharyngeal cells (Okkema and Fire,
1994). However, the basal promoter exhibits background
pharyngeal expression. Wenick and Hobert (2004) demon-
strated that the basal promoter is not necessary for the activity of
some enhancers. We therefore performed our enhancer assays
using a “promoterless” reporter, which showed no background
activity (Fig. 3C). When three copies of the predicted PHA-4
site from hlh-6 (ccgatTGTTTGCacagc) were placed upstream
of the promoterless GFP, they activated expression throughoutthe pharynx in 97% of transgenic animals (Fig. 3B), consistent
with this sequence responding to activation by PHA-4.
Our results suggest that hlh-6 expression is critically
dependent on a PHA-4 site at position −105. The core sequence
of this site (TGTTTGC) is identical to PHA-4 sites found in other
target genes, includingmyo-2, and has been shown to bind PHA-
4 in vitro with relatively high affinity (Gaudet and Mango,
2002). Two forkhead box (Fox) family members are reported to
be expressed in the pharynx (including the glands): pha-4 and
fkh-9 (Hope et al., 2003; Horner et al., 1998; Kalb et al.,
1998). However, available in situ hybridization data support
pharyngeal expression of pha-4 but not fkh-9 (Kohara, 2001a,b),
and fkh-9 RNAi has no observable phenotype. Therefore, we
propose that hlh-6 is a direct target of PHA-4.
Deletion analysis reveals three regions that contribute to hlh-6
expression
PHA-4 is expressed in all pharyngeal cells, not just the
glands. We therefore performed deletion analysis of min-hlh-6
to identify other sequences that were required for cell-type-
specific hlh-6 expression. Analysis of the minimal promoter
identified three regions (A–C) that contributed to hlh-6
expression (Fig. 4). Deletions from −241 to −213 (ΔA), from
−213 to −173 (ΔB) and from −173 to −140 (ΔC) each
decreased expression. For every construct tested, expression
was either specific to pharyngeal glands or absent; there were no
examples of expression outside of the glands. Interestingly,
Fig. 4. Three regions between −241 and −140 contribute to hlh-6 expression. Bar graphs are as in Fig. 1. Evidence from progressive 5′ deletions suggested that
sequence between −241 to −214 (region A), −213 to −176 (region B), and −175 to −140 (region C) each affected hlh-6 reporter expression. The critical PHA-4 site is
shown for reference.
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expression, as reporter constructs that contained only A (ΔBC)
or only C (ΔAB) activated gland-specific expression, while the
reporter lacking both A and C (ΔAC) showed no expression,
suggesting either a loss or significant reduction of promoter
activity. In contrast, region B was neither necessary (ΔB) nor
sufficient (ΔAC) for activity but enhanced the activity of
regions A and C. Specifically, A+B was more active than A
alone (ΔC vs. ΔBC), B+C was more active than C alone (ΔA
vs. ΔAB), and A+B+C was more active than A+C (min-hlh-6
vs.ΔB). The behavior of these three regions suggested that each
contained one or more discrete promoter elements that played a
role in regulation of hlh-6 expression.
Conservation of hlh-6 promoter sequence between C. elegans
and C. briggsae
To identify candidate regulatory elements in regions A–C of
the hlh-6 promoter, we examined conservation of sequences
between C. elegans hlh-6 and its ortholog in C. briggsae
(CBG06671, referred to here as Cb-hlh-6; Stein et al., 2003).
Overall, conservation of the hlh-6 promoter sequence was poor
(data not shown), but there was apparent conservation of small
stretches of sequence within the 100 bp that contains regions
A–C (Fig. 5).
Two of our functionally defined regions of the promoter
(B and C) contained short, conserved sequences, which we
refer to as hlh-6 candidate Regulatory eLements 1 and 2 (HRL1
and HRL2), respectively (Fig. 5). The contribution of these
elements to hlh-6 expression was analyzed in detail, as described
below. Interestingly, region A showed no extensive conservation
in C. briggsae, but did contain 8 bp (AATAAATA) that were
identical to the conserved sequence in region C (HRL2c). Giventhe redundant function of regions A and C described above, it
seemed likely that this AATAAATA sequence represented the
functional element of both region A and C.We therefore referred
to the AATAAATA sequences as HRL2a (in region A) and
HRL2c (in region C). Similarly, we referred to the other element
as HRL1b, as it lay within region B.
At least one HRL2 is required for hlh-6 expression
The combination of deletion analysis and phylogenetic
footprinting suggested that the copies of HRL2 found in regions
A and C were redundantly required for expression of the
minimal hlh-6 promoter. To specifically test the role of HRL2,
we removed one or both copies of this element from reporters
and scored their expression (Fig. 6). To remove HRL2a, we
used small deletions from the 5′ end of the minimal promoter
(Fig. 6). The first deletion (in Δ223) removed 18 bp, leaving
HRL2a intact, and had no effect on expression. The second
deletion (Δ213) removed an additional 10 bp, including most of
HRL2a, and reduced expression. Similarly, mutation of HRL2c
(from AATAAATA to AcccgggA) in the context of the minimal
promoter (ΔHRL2c) resulted in a moderate decrease in
expression. However, the simultaneous removal of HRL2a
and HRL2c (Δ213Δ2c) completely abolished gland expression.
When Δ213Δ2c was injected at higher concentration, some
animals (34%) showed weak expression in the pharynx
suggesting the presence of residual (but not gland-specific)
promoter activity. Given the shared AATAAATA sequence and
redundancy of HRL2a and HRL2c, we propose that these
sequences represent two copies of a promoter element necessary
for expression.
We next employed enhancer assays, using the same
promoterless vector used above (Fig. 3), to test whether HRL2
Fig. 5. Comparison of upstream sequence from C. elegans and C. briggsae revealed candidate hlh-6 regulatory eLements (HRL). The comparison was performed with
DotLet (Junier and Pagni, 2000), with a window size of 21 bp and a threshold of 60–65% identity. Functionally defined regions B and C corresponded to regions of
conserved sequence. Conserved sequences within these regions are shown at right.
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for gland-specific expression as three tandem copies (3xHRL2c)
activated weak expression in non-pharyngeal muscles of
embryos and young larvae (Fig. 7B, Table 2) while the empty
vector control showed no expression (Fig. 7A). Since min-hlh-6
expression required both a PHA-4 site and at least one copy of
HRL2 (Figs. 3 and 6), we tested the ability of a combination of
these two elements to activate expression. Three copies of a
PHA-4-binding site activated expression in many pharyngealFig. 6. The hlh-6 promoter contains two redundantly acting HRL2 sequences. Bar g
AATAAATA to AcccgggA;ΔHRL2c) reduced reporter expression, while simultaneo
loss of expression.cells (Figs. 3C and 7K), which would have obscured any
contribution of HRL2. We therefore used a single copy of a
PHA-4-binding site (1xPHA-4) together with 3xHRL2c. Similar
to previous reports (Gaudet et al., 2004; Okkema and Fire,
1994), a single PHA-4-binding site (1xPHA-4) had no activity in
the promoterless reporter (Fig. 7C, Table 2), but was able to
activate expression in combination with HRL2c. A PHA-4-
binding site and three copies of HRL2c (1xPHA-4+3xHRL2c;
we refer to combinations of elements according to their relativeraphs are as in Fig. 1. Deletion of HRL2a (Δ213) or mutation of HRL2c (from
us deletion of HRL2a and mutation of HRL2c (Δ213Δ2c) resulted in a complete
Fig. 7. Enhancer assays demonstrate combinatorial action of hlh-6 promoter elements. (A–L) Fluorescence images of animals transgenic for enhancer GFP constructs.
Dashed lines indicate the boundaries of the pharynx. (A) The promoterless vector pPD95.77 showed no expression in transgenic animals, which are marked by
expression of elt-2∷mRFP∷HIS2B or elt-2∷GFP∷LacZ in intestinal nuclei (arrowheads). (B) Three copies of HRL2c activated weak and infrequent expression in
embryonic body muscle (indicated by arrows, weaker signal is gut autofluorescence). (C) A single PHA-4 site placed upstream of a promoterless GFP reporter had no
observable activity. (D) The combination of 1xPHA-4 and 3xHRL2c resulted in strong expression in the posterior pharynx. The square bracket indicates the non-
expressing, MS-derived pm4 pharyngeal muscles. (E) A nuclear-localized version of the 1xPHA-4+3xHRL2c reporter allowed for the identification of individual
expressing cells, which reside in the posterior bulb. (F) Three copies of HRL1b in pPD95.77 activated expression in neurons in the head (arrowheads) and rare, weak
expression in pm6 pharyngeal muscles (arrows). (G) An enhancer construct containing both 1xPHA-4 and 3xHRL1b activated weak expression in non-pharyngeal
neurons (arrowheads) and rare expression in pm6 cells (arrows). (H) An enhancer construct containing both 3xHRL1b and 3xHRL2c resulted in expression in neurons
in the head. (I) The combination of 1xPHA-4, 3xHRL1b and 3xHRL2c produced robust, gland-specific expression. (J) The separation of 1xPHA-4 and 3xHRL2c
by a 28 bp spacer had no effect, as transgenics still exhibited expression in cells of the posterior pharynx (as in panel D). (K) Three copies of the PHA-4 site
(3xPHA-4) activated expression of a nuclear-localized GFP in pharyngeal cells located throughout the organ. (L) The combination of 3xPHA-4 and 3xHRL1b
(3xPHA-4+3xHRL1b) activated expression in pharyngeal glands and anteriorly-located pharyngeal neurons. A nuclear-localized GFP is shown; identity of the
glands was confirmed by testing a cytoplasmic version of the construct.
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the posterior half of the pharynx (Fig. 7D, Table 2), a behavior
that was not predicted from the activity of the individual
elements. Using a nuclear-localized version of the reporter, we
consistently observed expression in nuclei of several different
cell types within the pharynx (Fig. 7E), including muscle cells
(pm5, pm6, pm7), marginal cells (mc3) and gland cells.
Interestingly, the expressing cells are all descendents of the
MS blastomere, one of two blastomeres (ABa and MS) that give
rise to pharyngeal cells (Sulston et al., 1983). No ABa-derived
cells expressed GFP. However, not all MS-derived cells
expressed 1xPHA-4+3xHRL2c, as the pm4 cells of the anterior
bulb showed no expression (Fig. 8D, square bracket). Therefore,
the combination of 1xPHA-4 and 3xHRL2c activated expres-
sion in both a position (posterior) and lineage (MS-derived)
restricted manner. Consistent with a possible lineage-restricted
activity for HRL2, we note that at least some of the body muscle
cells that express the “3xHRL2c” (Fig. 7B) construct are
derivatives of the MS blastomere (Sulston et al., 1983).However, thorough analysis of the 3xHRL2c expression pattern
is limited by the relatively weak and infrequent expression of
this construct. Thus, we cannot rule out activity of HRL2c in
body muscle cells derived from other blastomeres and therefore
refer to this element as having “lineage-restricted” rather than
“lineage-specific” activity.
The combination of HRL1, HRL2 and PHA-4 recapitulates
hlh-6 gland-specific expression
Because 1xPHA-4+3xHRL2c together activated expression
in both gland and non-gland pharyngeal cells, we hypothesized
that some additional element(s) in the hlh-6 promoter further
restricted expression to gland cells. The most obvious candidate
was HRL1, so we tested the combination of three tandem copies
of HRL1b (3xHRL1b) with 1xPHA-4+3xHRL2c.
Alone, 3xHRL1b showed only occasional and weak expres-
sion in a subset of non-pharyngeal neurons in the head
(tentatively identified as URA neurons) and in a subset of
Table 2
Expression of enhancer constructs.
Construct Expression (% expressing transgenics) # Lines
No enhancer None (0%) 2
1xPHA-4 None (0%) 2
3xHRL2c Embryonic/early larval body muscle (18±2%); larval non-pharyngeal
head (52±2%)
2
1xPHA-4+3xHRL2c Posterior pharynx (94±5%) 4
3xHRL1b Unidentified head neurons (76±9%), pm6 (5±2%) 3
1xPHA-4+3xHRL1b Unidentified head neurons (73±7%), pm6 (8±4%) 2
3xHRL1b+3xHRL2c Unidentified head neurons (27±18%) 2
1xPHA-4+3xHRL1b+3xHRL2c Pharyngeal glands (61±15%); glands and posterior pharynx (39±14%) 3
1xPHA-4+spacer+3xHRL2c Posterior pharynx (92±3%) 3
3xPHA-4 Pharynx (broad; 97±5%) 3
3xPHA-4+3xHRL1b Pharyngeal glands and neurons only (62±11%); glands, neurons and
other pharyngeal cells (38±11%)
2
1xPHA-4+3xHRL1b+3xHRL2a Pharyngeal glands (75±15%); glands and posterior pharynx (5±5%) 3
1xPHA-4+3xHRL1b-mut+3xHRL2c Posterior pharynx (56±16%); glands and posterior pharynx (36±16%) 3
1xPHA-4+3xHRL1c+3xHRL2c Pharyngeal glands (64±3%); glands and posterior pharynx (35±3%) 3
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HRL1b had little enhancer activity. Similarly, pairwise
combinations of HRL1b with either of the two other elements
showed little activity: both 1xPHA-4+3xHRL1b (Fig. 7G,
Table 2) and 3xHRL1b+3xHRL2c (Fig. 7H, Table 2) behaved
no differently than 3xHRL1b alone. At most, this suggested that
3xHRL1b might block the weak activity of 3xHRL2c.
Remarkably, although the various elements on their own had
little or no activity, the combination of all three was sufficient toFig. 8. The hlh-6 promoter contains redundantly acting HRL1 sequences. Mutation o
identified another HRL1-related sequence, HRL1c. Percentages represent the fraction
those that exhibit expression in both pharyngeal glands and non-pharyngeal glan
(Δ155Δprox) resulted in decreased gland expression and the appearance of non-gland
3xHRL1b in the 1xPHA-4+3xHRL1b+HRL2c construct, and produced robust, glaactivate strong, gland-specific expression. Expression was
gland-specific in 61% of transgenic animals from three
independent transgenic lines (Fig. 7I), while the remaining
39% showed strong expression in glands and weaker expression
in non-gland cells of the posterior pharynx. These non-gland
pharyngeal cells appear to be the same as those that express the
1xPHA-4+3xHRL2c construct (data not shown). This result
suggested that HRL1b might function in part by repressing
expression in non-gland cells in 1xPHA+3xHRL2c. However,f HRL1b (HRL1b-mut) had no observable effect on expression. Further deletion
of transgenic animals that exhibit reporter expression in pharyngeal glands and
ds (typically non-pharyngeal neurons). (B) Removal of all HRL1 sequences
expression (arrowheads). (C) Three copies of HRL1c could functionally replace
nd-specific expression.
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specific expression of 1xPHA-4+3xHRL1b+3xHRL2c was
stronger than the expression observed with the 1xPHA-4+
3xHRL2c construct. Similar results were obtained by substitut-
ing HRL2a in place of HRL2c in the 1xPHA-4+3xHRL1+
3xHRL2 configuration. The combination of elements including
HRL2a resulted in gland-specific expression in 75% of
transgenic animals, albeit weaker than that obtained when
HRL2c is used (data not shown). This demonstrated that, as
argued above, HRL2a and HRL2c are functionally redundant
and likely represent two copies of the same promoter element.
Because the HRL1b sequence was inserted between the
PHA-4 and HRL2 elements, one possibility was that the
change of expression resulted from altered spacing between
the elements, rather than the introduction of HRL1b sequence.
We therefore tested a construct in which we placed unrelated
sequence (from the vector) between 1xPHA-4 and 3xHRL2c.
This construct exhibited consistent expression in both gland
and non-gland cells in the posterior pharynx (Fig. 7J, Table
2), as observed for the original 1xPHA-4+3xHRL2c
construct. Thus, HRL1b functioned to repress expression of
1xPHA-4+3xHRL2c in non-gland pharyngeal cells and to
enhance expression in gland cells.
Given the apparent repressive role of HRL1b, one possible
model was that HRL1 in combination with one copy of PHA-4
might be sufficient to restrict expression to gland cells, and that
HRL2 merely increased the strength of that expression. To test
this possibility, we combined 3xPHA-4 with 3xHRL1b. As
seen before, the 3xPHA-4 construct activated expression in
many pharyngeal cells, including cells derived from both ABa
and MS, as well as examples of all five types of pharyngeal cell
(Fig. 7K and data not shown). In contrast, the 3xPHA-4
+3xHRL1b combination was expressed in only a subset of
pharyngeal cells. Based on expression of both nuclear and
cytoplasmic versions of this reporter, expressing cells were
identified as ABa-derived neurons (NSM, MC and I2 neurons)
and the glands. Expression in pharyngeal neurons and glands
appeared stronger than the pharyngeal expression seen with
3xPHA-4, suggesting that HRL1b activated expression in these
cells, while other pharyngeal cells showed greatly reduced or
no expression, suggesting that HRL1b repressed expression in
these cells.
Multiple copies of HRL1 contribute to hlh-6 expression
Given the behavior of HRL1b in our enhancer assays, we
tested the effects of mutating HRL1b in the context ofmin-hlh-6.
Our expectation was that the removal of HRL1b would result in
ectopic expression (loss of repression), a decrease in expression
(loss of activation) or both. However, mutation of HRL1b from
GTCGGAAG to GTCtagAG had no observable effect on min-
hlh-6 expression (Fig. 8; HRL1b-mut). To verify that this
mutation eliminated HRL1b, we constructed and tested
“1xPHA-4+3xHRL1b-mut+3xHRL2”. This enhancer acti-
vated expression in the posterior pharynx of most transgenic
animals, while roughly one-third showed weak expression in the
posterior pharynx with stronger expression in the glands (Table2). This result suggests that the HRL1b-mut reduces but does not
completely abolish HRL1b activity, which could account for the
observation that the HRL1b mutation had no effect onmin-hlh-6
expression. To completely remove HRL1b, we generated a
deletion (Δ173Δprox) that removed HRL1b and surrounding
sequence. The only observable effect of this deletion on
expression was the occurrence of weak expression in non-
pharyngeal neurons of 17% of transgenic animals. This result
suggests that HRL1b may not be required for min-hlh-6 activity
or that there are other promoter elements (such as other copies of
HRL1) that are functionally redundant with HRL1b. We favored
the latter hypothesis, based on our enhancer assay results, and
therefore performed further analysis ofmin-hlh-6 to identify any
HRL1b-related sequences.
At best, min-hlh-6 contained only poor matches to HRL1b:
searches for GTCGGAAG with 0–2 mismatches identified only
the original HRL1b sequence, while searches for sites with 3
mismatches identified five sites in addition to HRL1b. Thus, if
min-hlh-6 contained elements that were functionally redundant
with HRL1b, they were not close in sequence composition.
However, further deletion analysis of min-hlh-6 identified a
HRL1-like sequence (HRL1c, as it was located in region C) that
was required for gland-specific expression. Removal of
significant portions of min-hlh-6 (Δ173Δprox and
Δ163Δprox) had little effect on gland-specific expression. We
did observe occasional expression outside the pharynx for both
Δ173Δprox and Δ163Δprox (Fig. 8), but this expression was
confined to one or two cells and was very weak. However,
removal of an additional 9 bp from Δ163Δprox (to generate
Δ155Δprox) resulted in both a reduction of gland expression
and an increase in non-gland expression: ectopic expression was
consistently observed in several non-pharyngeal neurons. This
result fit our expectations from the enhancer assays in which
HRL1 behaved as both a repressor and activator. The 9 bp
segment required for gland-specific expression included a
poor match to HRL1b that we named HRL1c (GTG-
GCTAA; matches to HRL1b are underlined).
To test whether HRL1c was functionally equivalent to
HRL1b, we tested its activity in our enhancer constructs. Three
tandem copies of HRL1c (3xHRL1c) could functionally replace
3xHRL1b in the 1xPHA-4+3xHRL1+3xHRL2 construct (Fig.
8C and Table 2). The results from promoter and enhancer
analyses suggested that min-hlh-6 contained at least two copies
of HRL1 (b and c) that functioned as both activators of ex-
pression in pharyngeal glands and repressors of expression in
non-gland cells.
Discussion
Three elements function combinatorially to regulate
gland-specific expression of hlh-6
Our model outlines two regulatory mechanisms by which
hlh-6 expression is restricted to pharyngeal glands (Fig. 9).
First, hlh-6 is activated by PHA-4, which provides organ-
specific activation of hlh-6, and by HRL2, which provides
position- and lineage-restricted activation. Complete removal of
Fig. 9. (A) Sequence of the minimal 241 bp hlh-6 promoter, showing the positions of identified regulatory elements. (B) Schematic diagram of how the different
promoter elements may function to restrict hlh-6 expression to pharyngeal glands. Grey regions do not express hlh-6 either because of repression (in MS-derived non-
gland cells) or insufficient activation (in ABa neurons).
305I. Raharjo, J. Gaudet / Developmental Biology 302 (2007) 295–308either element from the hlh-6 promoter is sufficient to eliminate
expression, arguing that it is the combined and presumably
overlapping expression of the relevant regulators (PHA-4 and
an unknown HRL2-binding factor) that restricts expression of
hlh-6 to the posterior, MS-derived pharyngeal cells, including
glands. This type of regulatory mechanism, in which activation
of gene expression occurs in a region where two or more
transcription factors are co-expressed, is common in specifica-
tion of neuronal subtypes (for examples, see Allan et al., 2003;
Wang and Harris, 2005; Wenick and Hobert, 2004) and appears
to be a common feature in gene regulation (reviewed in
Davidson, 2006). The second regulatory mechanism at work is
both repression and activation via HRL1, which appears to
enhance expression in secretory cells (neurons and glands) and
repress expression in non-secretory cells. This type of dual
repressor/activator function is a central feature of gene
regulation by signaling pathways (reviewed in Barolo and
Posakony, 2002) and the use of repressors to refine domains of
gene expression is a hallmark of pattern formation in Droso-
phila embryos (Ip and Hemavathy, 1997), as well as in other
systems. In the case of hlh-6, the combination of HRL1 with
PHA-4 and HRL2 results in specific expression in pharyngeal
glands. Although HRL1 appears to also permit or activate
expression in anterior pharyngeal neurons (Fig. 7L), it does so
only when PHA-4 sites are present in multiple copies and not in
combination with a single PHA-4 site (Fig. 7G). This may
explain why hlh-6, which appears to contain only a single
functional PHA-4 site, is not expressed in anterior pharyngeal
neurons.The combination of the “1xPHA-4+3xHRL1+3xHRL2”
promoter elements is sufficient to recapitulate hlh-6 expression,
arguing that these elements are the essential components of the
hlh-6 promoter. One inconsistency is that the absence of HRL1
sequences in the enhancer constructs results in broader
expression only within the pharynx, while the removal of
HRL1 sequences from the hlh-6 promoter (Δ155Δprox) gene-
rates ectopic expression outside the pharynx. Two possible
explanations could account for this discrepancy. First, there may
be additional copies of HRL1 present in the promoter that we
have not removed. Because HRL1 is defined by only two
sequences (HRL1b and HRL1c), we may not be able to
recognize all functional versions of this element. The second
possibility is that other, unidentified elements in the hlh-6 pro-
moter have an overlapping and partially redundant function to
HRL1. Nonetheless, the behavior of the 1xPHA-4+3xHRL1+
3xHRL2 constructs demonstrates that we have identified core
components of a combinatorial code for pharyngeal gland
expression.
Other elements present in the hlh-6 promoter may play
relatively minor roles in the stabilization of the expression
pattern. An example of this is the pair of probable HLH-6-
binding sites at −427 and −349, which may function in
maintenance of expression. One prediction of such a model is
that the removal of these maintenance sites should not affect
onset of hlh-6 expression, while a promoter that is largely
dependent on these sites would have a later onset of expression.
Expression of the full-length hlh-6 reporter is first visible in late
bean stage embryos (Smit and Gaudet, in preparation), while
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sites) is first visible ∼50 min later in comma stage embryos and
Δ747Δmin (which lacks HRL1 and HRL2 sites) is visible
another ∼40 min later in 1 ½-fold embryos (our unpublished
data). While these results are consistent with a maintenance role
for HLH-6 autoregulation, they may simply reflect the relative
strength of each reporter, with stronger reporters reaching a
threshold for detection prior to weaker reporters. Autoregulation
of hlh-6 may serve to reinforce the specificity of gland
expression, as expression of the probable dimerization partner
of HLH-6 (the C. elegans Daughterless homolog, HLH-2;
Krause et al., 1997; Smit and Gaudet, in preparation) appears to
be restricted to gland cells. In addition to the autoregulatory
sites, other elements in region B appear to contribute to the
strength of hlh-6 expression. The only element identified in
region B is HRL1b, yet its removal had no observable effect on
expression because of the presence of other HRL1 sequences
outside of region B. Therefore, region B probably contains at
least one other element that contributes to the strength of hlh-6
expression, but is not essential for generation of the gland-
specific pattern of expression.
hlh-6 as an integrator of diverse transcriptional inputs
The hlh-6 promoter appears to be a point of integration for
diverse transcriptional inputs. One interesting feature of these
inputs is that they appear to correspond to discrete character-
istics of pharyngeal gland cells: PHA-4 is organ-specific, HRL2
is position- and lineage-restricted, and HRL1 has a dual role of
enhancing expression in neurosecretory cells and repressing
activity in other cell types.
hlh-6 not only integrates diverse transcriptional inputs to
achieve gland-specific expression, but also then passes on this
information to a battery of gland-specific genes (Smit and
Gaudet, in preparation). In fact, the hlh-6-binding site is itself
sufficient to activate gland-specific expression, in sharp contrast
to the requirement for three distinct elements for its own
expression. Rather than requiring that potentially hundreds of
gland-specific genes be subject to the regulatory action of three
distinct factors, the instructional load is shifted to a single
regulator, effectively reducing the complexity of the network.
Consistent with this idea, downstream targets of HLH-6 do not
contain recognizable HRL1 or HRL2 elements: of the
promoters of five verified hlh-6 targets (Smit and Gaudet, in
preparation), only one contained a possible HRL1 sequence and
none contained a HRL2 sequence (data not shown).
Another feature of the hlh-6 promoter is that two of the
regulatory elements (HRL1 and HRL2) are present in multiple
copies and function with some degree of redundancy. In
addition, the relative position of these elements does not appear
to be a critical feature of the promoter, as the arbitrary posi-
tioning of these elements in our enhancer constructs does not
appear to limit their function. The presence of multiple copies of
individual elements is a common feature in promoters
(Markstein et al., 2002; Yoo et al., 2004), and likely functions
to enhance and stabilize an expression pattern. This insulation is
especially important in the case of an essential gene like hlh-6,which is positioned upstream of an entire battery of genes that
depend on hlh-6.
Candidate regulators of hlh-6 expression
An important next step will be to identify the transcription
factors that function through HRL1 and HRL2. The sequence
and in vivo activity of these elements suggest a few possibilities.
First, the complement to HRL2 (TATTTATT) resembles a
forkhead box (Fox)-binding site (TRTTKRY). Four lines of
evidence suggest that HRL2 is not, however, a binding site for
PHA-4/FoxA. First, in enhancer assays, HRL2 does not behave
like a PHA-4-binding site. Second, in combinatorial enhancer
constructs, HRL2 shows synergistic activity when coupled with
a bona fide PHA-4 site. Third, in the hlh-6 promoter, HRL2 is
not sufficient to activate expression in the absence of the
verified PHA-4-binding site. Fourth, PHA-4 does not bind to
TATTTAT in vitro (Gaudet and Mango, 2002; Gaudet et al.,
2004). Therefore, HRL2 may be a binding site for one of the
other 15 C. elegans Fox genes. However, the expression pattern
of all 15 Fox genes has been analyzed, and none of these appear
to be expressed in the posterior pharynx, where the 1xPHA-4+
3xHRL2c construct expresses (Hope et al., 2003). HRL2 also
resembles the binding site for the myogenic bHLH cofactor
MEF-2, which recognizes the sequence CTAWWWWTAG
(Shore and Sharrocks, 1995). However, C. elegans mef-2 is
broadly expressed and mef-2 mutants are superficially wild type
(Dichoso et al., 2000), whereas we predict that loss of an
activator of hlh-6 should (at least) phenocopy hlh-6 mutants
and result in larval lethality. While we cannot completely rule
out the involvement of a Fox factor or MEF-2, it seems likely
that some other factor binds HRL2.
HRL1b and HRL1c are functionally interchangeable in
enhancer assays, and have the shared sequence GTSGSWAR
(where S=C or G, W=A or T, and R=A or G). This sequence
appears to have both activator and repressor functions, and
resembles the consensus binding site for CSL (CBP1/Su(H)/
LAG-1) transcription factors (GTGGGAA; Chung et al.,
1994; Tun et al., 1994). CSL factors are the downstream
effectors of Notch signaling, raising the interesting possibility
that hlh-6 is a direct target of Notch activity (Barolo et al.,
2000). Furthermore, Notch signaling is known to be important
in other organisms, such as mouse, chick and Drosophila, for
specification of digestive tract glands (Haberman et al., 2003;
Jhappan et al., 1992; Matsuda et al., 2005). However, HRL1b
and HRL1c are not identical to the CSL consensus sequence
and sequences resembling HRL1c (GTGGCAA and GTG-
GGTA; HRL1c=GTGGCTA) do not bind to Su(H) in vitro,
suggesting that HRL1 may not be recognized by CSL (Bailey
and Posakony, 1995). In C. elegans, the only characterized
sites for the CSL factor LAG-1 are RTGGGAA and
YRTGRGAA (Christensen et al., 1996; Gupta and Sternberg,
2002; Yoo et al., 2004), but it remains possible that LAG-1
may be able to bind to additional, related sequences. We
tested the expression of hlh-6∷YFP in lag-1 mutants and
observed ectopic expression, which is consistent with LAG-1
acting through HRL1 (data not shown). However, because
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the developing embryo (for example, Neves and Priess, 2005)
it remains possible that the effect of lag-1 on hlh-6 expression
is indirect and results from an earlier defect in cell fate
specification rather than a direct effect on gene expression.
In mammals, bHLH genes often function in regulatory
cascades (Schuurmans et al., 2004; Tapscott, 2005) yet we find
no evidence for such regulation of hlh-6. Although the hlh-6
promoter contains E-box sequences (potential binding sites for
bHLH genes), the only such sequence that appears to be func-
tional apparently responds to hlh-6 autoregulation rather than
regulation by a different bHLH. Similarly, while some bHLH
genes are targets of the HES family of transcription factors
(Ishibashi et al., 1995; Sasai et al., 1992), there is no evidence
for a functional HES-binding site (N box) in the hlh-6
promoter. In C. elegans, the REF group of bHLH transcription
factors appears to fulfill the role of the HES factors (Neves and
Priess, 2005). REF proteins bind to E-boxes, yet the E-box
sequences in hlh-6 are probably autoregulatory rather than
repressive, suggesting that REF proteins do not act upon the
hlh-6 promoter. Instead, pharyngeal gland-specific expression
of hlh-6 is regulated by the combined action of a PHA-4-
binding site and the two newly identified sequences, HRL1 and
HRL2.
Specification of other pharyngeal cell types
The logic utilized in gland-specific expression of hlh-6 likely
reflects an underlying cell fate specification, and a similar logic
may be used by other promoters that function in other distinct
pharyngeal cell types. For example, expression of genes in non-
gland MS-derived pharyngeal cells may be achieved through
the combined activity of PHA-4 and HRL2 acting together with
a third (non-HRL1) element. Similarly, PHA-4 and HRL1 may
function with an ABa-restricted element acting in place of
HRL2 to activate expression in a subset of anterior pharyngeal
neurons. Thus, the apparent modularity of the hlh-6 promoter
could be applied to many other cell-type-specific expression
patterns within the pharynx. It is not likely to be this simple in
all cases, however, as some pharyngeal cell types (such as
muscles and marginal cells) are descendants of both the ABa
and MS blastomeres (Sulston et al., 1983). In these cases,
lineage-specific information could be utilized to distinguish
between cell subtypes (such as anterior muscle vs. posterior
muscle), as suggested by recent findings (Broitman-Maduro et
al., 2006; Roy Chowdhuri et al., 2006).
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